Matches in Wikidata for { <http://www.wikidata.org/entity/Q89022785> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q89022785 description "artículu científicu espublizáu en mayu de 2018" @default.
- Q89022785 description "scientific article published on 01 May 2018" @default.
- Q89022785 description "wetenschappelijk artikel" @default.
- Q89022785 description "наукова стаття, опублікована в травні 2018" @default.
- Q89022785 name "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 name "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 type Item @default.
- Q89022785 label "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 label "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 prefLabel "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 prefLabel "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 P1104 Q89022785-28096ACF-3EC2-4DC1-B722-0FC5359D6E77 @default.
- Q89022785 P1433 Q89022785-D75E1CD0-09C5-442D-BFBB-FE7DF2BEBE47 @default.
- Q89022785 P1476 Q89022785-91E904C9-12CD-469C-89BF-4C4F183BDBC4 @default.
- Q89022785 P2093 Q89022785-51770E05-A8AE-4291-9B6F-236E3FE38B30 @default.
- Q89022785 P2093 Q89022785-594D11EE-ABAD-44F5-9B01-70DA77E2F69A @default.
- Q89022785 P2093 Q89022785-78914DF2-54C2-4E43-93F5-230A9D68D6A6 @default.
- Q89022785 P304 Q89022785-0D768A1A-6F4B-4B8D-9DB7-D66CCEA65F3E @default.
- Q89022785 P31 Q89022785-956918B7-647B-4B91-BB5A-E7C1A58B9F1A @default.
- Q89022785 P356 Q89022785-05C1FAD8-9DF9-49D2-B9A8-3A28142FE28B @default.
- Q89022785 P433 Q89022785-9AB68B16-2500-41E0-A116-5BC00B042FDB @default.
- Q89022785 P478 Q89022785-AB7E3B0D-094D-408A-A5D9-A2B564AB6808 @default.
- Q89022785 P50 Q89022785-2ECAD808-BFAB-49D1-B6B2-8ACEF18E40B7 @default.
- Q89022785 P577 Q89022785-8D45EB8E-4B15-4412-BBEA-62931A65642C @default.
- Q89022785 P698 Q89022785-1EAF055B-4C4A-4337-91CB-34E12C14D97F @default.
- Q89022785 P921 Q89022785-2AA3FA09-B40C-4B0C-8206-BB1AEB7CEFEE @default.
- Q89022785 P356 HEAD.13309 @default.
- Q89022785 P698 29878341 @default.
- Q89022785 P1104 "+12" @default.
- Q89022785 P1433 Q5689497 @default.
- Q89022785 P1476 "DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study" @default.
- Q89022785 P2093 "Alan M Rapoport" @default.
- Q89022785 P2093 "Elimor Brand-Schieber" @default.
- Q89022785 P2093 "Sagar Munjal" @default.
- Q89022785 P304 "676-687" @default.
- Q89022785 P31 Q13442814 @default.
- Q89022785 P356 "10.1111/HEAD.13309" @default.
- Q89022785 P433 "5" @default.
- Q89022785 P478 "58" @default.
- Q89022785 P50 Q56957375 @default.
- Q89022785 P577 "2018-05-01T00:00:00Z" @default.
- Q89022785 P698 "29878341" @default.
- Q89022785 P921 Q269829 @default.